Oric Pharmaceuticals ROA 2024

Oric Pharmaceuticals Aktienanalyse

What does Oric Pharmaceuticals do?

Oric Pharmaceuticals Inc. is a biotechnology company focused on the discovery and development of novel therapeutic approaches for cancer. The company was founded in 2014 by an experienced management team and reputable investors with extensive knowledge in the development and commercialization of cancer drugs. The company is headquartered in Durham, North Carolina, USA. Oric Pharmaceuticals operates a unique business model that focuses on the development of drugs that specifically target cancer cells, thereby increasing therapeutic effectiveness and reducing side effects. The company utilizes a combination of advanced technologies such as genomics, proteomics, and artificial intelligence to develop novel compounds and treatment approaches. The company conducts its research in two business areas: 1) Refinement of the Oric-006 program: The Oric-006 program is a focus of Oric Pharmaceuticals, involving a novel approach to combating cancer. The company has discovered that the protein kinase inhibitor, or Oric-006, is capable of killing tumor cells in patients with advanced tumors. Additionally, the medication is able to slow the spread and inhibit the growth of cancer cells. The company is researching the refinement of Oric-006 and is currently in phase 1b/2 clinical trials. 2) Development of additional compounds: Oric Pharmaceuticals focuses on the development of further therapeutic approaches that can be specifically utilized against specific types of cancer. The company is working on various technologies and platforms to develop new compounds and test their effects against cancer cells. Oric Pharmaceuticals' products have the potential to positively impact the lives of cancer patients and reduce the need for chemotherapy and radiation therapy. The company recognizes the necessity for personalized medicine and utilizes it in the identification of new therapeutic approaches. The company plans to bring its products to market through partnerships and targeted marketing. Oric Pharmaceuticals collaborates closely with experts and leading research institutions for the marketing of their products. Overall, Oric Pharmaceuticals is an innovative company that could play a leading role in the industry due to its focus on personalized cancer medicine and the utilization of cutting-edge technologies. With an experienced management team and reputable investors, the company is positioned for further growth in the future. Oric Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROA Details

Understanding Oric Pharmaceuticals's Return on Assets (ROA)

Oric Pharmaceuticals's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Oric Pharmaceuticals's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Oric Pharmaceuticals's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Oric Pharmaceuticals’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Oric Pharmaceuticals stock

What is the Return on Assets (ROA) of Oric Pharmaceuticals this year?

The Return on Assets (ROA) of Oric Pharmaceuticals is -0.4 undefined this year.

What was the ROA of Oric Pharmaceuticals compared to the previous year?

The ROA of Oric Pharmaceuticals has increased by 10.84% compared to the previous year.

What consequences do high ROA have for investors of Oric Pharmaceuticals?

A high ROA is advantageous for investors of Oric Pharmaceuticals, as it indicates that the company efficiently utilizes its assets and generates good profits.

What are the consequences of low ROA for investors in Oric Pharmaceuticals?

A low ROA can be unfavorable for investors of Oric Pharmaceuticals as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.

How does an increase in the ROA of Oric Pharmaceuticals affect the company?

An increase in ROA of Oric Pharmaceuticals can be an indicator of improved efficiency in asset utilization and higher profitability.

How does a reduction in ROA of Oric Pharmaceuticals impact the company?

A reduction in the ROA of Oric Pharmaceuticals can be an indicator of lower asset efficiency and profitability.

What are some factors that can influence the ROA of Oric Pharmaceuticals?

Some factors that can influence the ROA of Oric Pharmaceuticals include revenue, operating costs, asset structure, and industry average.

Why is the ROA of Oric Pharmaceuticals important for investors?

The ROA of Oric Pharmaceuticals is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.

What strategic measures can Oric Pharmaceuticals take to improve ROA?

To improve ROA, Oric Pharmaceuticals can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.

How much dividend does Oric Pharmaceuticals pay?

Over the past 12 months, Oric Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oric Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Oric Pharmaceuticals?

The current dividend yield of Oric Pharmaceuticals is .

When does Oric Pharmaceuticals pay dividends?

Oric Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oric Pharmaceuticals?

Oric Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Oric Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oric Pharmaceuticals located?

Oric Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oric Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oric Pharmaceuticals from 9/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/18/2024.

When did Oric Pharmaceuticals pay the last dividend?

The last dividend was paid out on 9/18/2024.

What was the dividend of Oric Pharmaceuticals in the year 2023?

In the year 2023, Oric Pharmaceuticals distributed 0 USD as dividends.

In which currency does Oric Pharmaceuticals pay out the dividend?

The dividends of Oric Pharmaceuticals are distributed in USD.